Fig. 1From: LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPCCEBPA-DT is upregulated in HCC with extrahepatic metastasis and associated with patient prognosis. A Clustering plot of differential lncRNA profiles between HCC tissues with or without extrahepatic metastasis. B Volcano plot of differential lncRNA profiles between HCC tissues with or without extrahepatic metastasis. C Relative RNA levels of 6 candidate lncRNAs in 22 HCC tissues with or without extrahepatic metastasis. D Relative CEBPA-DT expression levels in 54 paired HCC tissues and non-tumor tissues in West China Hospital cohort. E Kaplan–Meier curves showed relationship between CEBPA-DT expression and overall survival (left) or recurrence-free survival (right) in 88 HCC patients from West China Hospital cohort. F Relative CEBPA-DT expression levels in 50 paired HCC tissues and non-tumor tissues in TCGA cohort. G Kaplan–Meier curves showed relationship between CEBPA-DT expression and overall survival (left) or recurrence-free survival (right) in 317 HCC patients from TCGA LIHC cohort. *p < 0.05, **p < 0.01, ***p < 0.001Back to article page